Experts develop groundbreaking new anti-ageing serum

17 Apr 2012

1

A new No7 serum available exclusively at Boots stores in the UK, proven by one of the world's leading pigmentation experts to shrink and fade age spots, has been developed in conjunction with the University of Bradford's Centre for Skin Sciences, UK.
 
No7 Lift & Luminate Day & Night Serum, available in Boots stores nationwide from 18 April 2012, is proven to tackle the three key signs of ageing - lines and wrinkles, loss of firmness and uneven pigmentation for skin in people above 45.
 
Boots experts worked with Des Tobin, professor of cell biology and director of the Centre of Skin Sciences at the Universityof Bradford, to develop their unique formulation.

Prof. Tobin and his team established in the lab setting how active ingredients derived from natural extracts may influence how the skin's pigment-forming cells (melanocytes) communicate with other skin cells, to address ageing-associated skin pigmentation irregularities.
 
The experts carried out a clinical trial, which demonstrated a significant fading of age spots after two months use. After a further two months 75 per cent of volunteers who used the serum showed fading of age spot colour versus 78 per cent for Hydroquinone, with cumulative benefits shown over time. This breakthrough clinical trial is the latest step on Boots journey to provide further compelling proof of the performance of its products.
 
No7 Lift & Luminate Day & Night Serum combines the existing technology of No7 Protect & Perfect with a groundbreaking new formulation that is clinically proven to lighten and shrink age spots from two months onwards.
 
With proven solutions for women of all ages, No7 now has 3 clinically proven anti-ageing serums:

    For women aged 25-35, No7 Protect & Perfect Beauty Serum addresses the appearance of fine lines and wrinkles
    Whilst for those aged 35-45, No7 Protect & Perfect Intense Beauty Serum targets deeper lines and wrinkles
    For the first time, New No7 Lift & Luminate Day & Night Serum for women aged 45+ tackles lines and wrinkles, loss of firmness and uneven pigmentation 

Dr Mike Bell, Scientific Skincare Advisor for Boots, said of the trial, ''I believe this is the first time a product has been tested against 4 per cent Hydroquinone in a real usage setting to assess the benefits on age spots. Once again No7  is changing the face of anti-ageing providing clear proof and visible results in a widely available skincare product.''
 
No7 Lift & Luminate Day & Night Serum has been tested in more than 20 studies including three separate clinical trials and on over 1,200 women.

Latest articles

Starlink Enters Gujarat: Musk-Linked Satellite Internet Deal Targets Remote Connectivity

Starlink Enters Gujarat: Musk-Linked Satellite Internet Deal Targets Remote Connectivity

Adani Energy Secures Japanese Bank Funding for Major North India Transmission Project

Adani Energy Secures Japanese Bank Funding for Major North India Transmission Project

Advent, FedEx-Led Group to Acquire Parcel Locker Firm InPost in $9.2 Billion Deal

Advent, FedEx-Led Group to Acquire Parcel Locker Firm InPost in $9.2 Billion Deal

Taiwan Says Shifting 40% of Chip Capacity to U.S. Is ‘Impossible’

Taiwan Says Shifting 40% of Chip Capacity to U.S. Is ‘Impossible’

U.S. Treasury’s Bessent Says Fed Likely to Move Slowly on Balance Sheet Decisions

U.S. Treasury’s Bessent Says Fed Likely to Move Slowly on Balance Sheet Decisions

Saudi Arabia Orders 20 High-Speed Trains From Spain’s Talgo

Saudi Arabia Orders 20 High-Speed Trains From Spain’s Talgo

Investors Rotate Into Smaller, Cheaper Stocks as Tech Risk Appetite Fades

Investors Rotate Into Smaller, Cheaper Stocks as Tech Risk Appetite Fades

Global Chip Sales Expected to Hit $1 Trillion This Year, Industry Group Says

Global Chip Sales Expected to Hit $1 Trillion This Year, Industry Group Says

Citi to Match Government Seed Funding for Children’s ‘Trump Accounts’

Citi to Match Government Seed Funding for Children’s ‘Trump Accounts’